Thermogenesis Holdings, Inc. (THMO) News
Filter THMO News Items
THMO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
THMO News Highlights
- For THMO, its 30 day story count is now at 3.
- Over the past 24 days, the trend for THMO's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
Latest THMO News From Around the Web
Below are the latest news stories about THERMOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate THMO as an investment opportunity.
Shareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time BeingKey Insights ThermoGenesis Holdings will host its Annual General Meeting on 14th of December Salary of US$519.0k is... |
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call TranscriptThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Good day. And welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Third Quarter ended September 30, 2023. As a reminder, this call is being recorded today. I would now like to turn the […] |
Q3 2023 Thermogenesis Holdings Inc Earnings CallQ3 2023 Thermogenesis Holdings Inc Earnings Call |
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update. |
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET. |
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater SacramentoThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and cell and gene therapy services, announced the grand opening of its new state-of-the-art facility, housing ISO 7 cGMP cleanroom suites, along with research and development labs. The Grand Opening Celebration for the ReadyStart Cleanrooms and IncuStart Wet Labs was held today at the facility located at 2890 Kilgore Rd., Rancho Cordova, CA 95670. |
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET, during the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023, in New York. |
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call TranscriptThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call Transcript August 11, 2023 Operator: Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023. [Operator Instructions]. As a reminder, this conference call is being recorded. I would now like to […] |
Q2 2023 Thermogenesis Holdings Inc Earnings CallQ2 2023 Thermogenesis Holdings Inc Earnings Call |
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update. |